| Product Code: ETC9979531 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Whole Genome and Exome Sequencing Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Whole Genome and Exome Sequencing Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Whole Genome and Exome Sequencing Market - Industry Life Cycle |
3.4 United States (US) Whole Genome and Exome Sequencing Market - Porter's Five Forces |
3.5 United States (US) Whole Genome and Exome Sequencing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Whole Genome and Exome Sequencing Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 United States (US) Whole Genome and Exome Sequencing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and precision healthcare |
4.2.2 Technological advancements in sequencing platforms leading to cost reduction and improved efficiency |
4.2.3 Rising prevalence of genetic disorders and chronic diseases driving the need for genetic testing |
4.3 Market Restraints |
4.3.1 High cost associated with whole genome and exome sequencing limiting adoption |
4.3.2 Concerns regarding data privacy and ethical implications of genetic testing |
4.3.3 Limited reimbursement policies for genetic testing services |
5 United States (US) Whole Genome and Exome Sequencing Market Trends |
6 United States (US) Whole Genome and Exome Sequencing Market, By Types |
6.1 United States (US) Whole Genome and Exome Sequencing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Whole Genome and Exome Sequencing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Whole Genome and Exome Sequencing Market Revenues & Volume, By Kits, 2021- 2031F |
6.1.4 United States (US) Whole Genome and Exome Sequencing Market Revenues & Volume, By Instruments, 2021- 2031F |
6.2 United States (US) Whole Genome and Exome Sequencing Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Whole Genome and Exome Sequencing Market Revenues & Volume, By Hospitals and Clinics, 2021- 2031F |
6.2.3 United States (US) Whole Genome and Exome Sequencing Market Revenues & Volume, By Pharmaceutical and Biotechnology Companies, 2021- 2031F |
6.2.4 United States (US) Whole Genome and Exome Sequencing Market Revenues & Volume, By Diagnostic Labs, 2021- 2031F |
6.2.5 United States (US) Whole Genome and Exome Sequencing Market Revenues & Volume, By Research Centres, 2021- 2031F |
6.2.6 United States (US) Whole Genome and Exome Sequencing Market Revenues & Volume, By Academia and Government Institutes, 2021- 2031F |
6.2.7 United States (US) Whole Genome and Exome Sequencing Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Whole Genome and Exome Sequencing Market Import-Export Trade Statistics |
7.1 United States (US) Whole Genome and Exome Sequencing Market Export to Major Countries |
7.2 United States (US) Whole Genome and Exome Sequencing Market Imports from Major Countries |
8 United States (US) Whole Genome and Exome Sequencing Market Key Performance Indicators |
8.1 Average turnaround time for sequencing services |
8.2 Adoption rate of next-generation sequencing technologies |
8.3 Number of research collaborations and partnerships in the genomics industry |
9 United States (US) Whole Genome and Exome Sequencing Market - Opportunity Assessment |
9.1 United States (US) Whole Genome and Exome Sequencing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Whole Genome and Exome Sequencing Market Opportunity Assessment, By Application, 2021 & 2031F |
10 United States (US) Whole Genome and Exome Sequencing Market - Competitive Landscape |
10.1 United States (US) Whole Genome and Exome Sequencing Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Whole Genome and Exome Sequencing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here